We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

1 hedge funds and large institutions have $101 invested in Amedisys in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

75% less funds holding

Funds holding: 41 (-3)

100% less capital invested

Capital invested by funds: $57.6K → $101 (-$57.5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

AMED Hedge Fund Activity: Q4 2025 in Review

1 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2025, worth a combined $101 — down 100% from $57.6K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AMED and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Osaic Holdings, exiting entirely with an estimated $47.7K sold.

  • 1 institutional investor held Amedisys (AMED) as of Q4 2025, down from 4 in Q3 2025.
  • Funds reported $101 of Amedisys stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Amedisys positions in Q4 2025 and 3 closed out, a net change of -3 holders.
  • The largest Amedisys seller in Q4 2025 was Osaic Holdings, an estimated $47.7K sold.

Based on aggregated 13F filings for Q4 2025.